| http://dbpedia.org/ontology/abstract
|
Icos Corporation (merek dagang ICOS) adala … Icos Corporation (merek dagang ICOS) adalah perusahaan bioteknologi Amerika dan perusahaan bioteknologi terbesar di negara bagian AS yaitu Washington, sebelum dijual kepada Eli Lilly And Company pada tahun 2007. Didirikan pada tahun 1989 oleh , , , dan , pelopor dalam industri dan Chief Executive Officer (CEO) dan co-founder dari Amgen, Icos difokuskan pada pengembangan obat-obatan untuk mengobati gangguan inflamasi. Selama sejarah 17 tahun, perusahaan melakukan dari dua belas narkoba, tiga di antaranya mencapai tahap terakhir dari uji klinis. Icos juga diproduksi antibodi untuk perusahaan bioteknologi lain.tibodi untuk perusahaan bioteknologi lain.
, Icos (торговая марка ICOS) — корпорация, б … Icos (торговая марка ICOS) — корпорация, была крупнейшей на рынке биотехнологий в Вашингтоне (США) прежде, чем была продана компании Eli Lilly and Company в 2007 году . Компания Icos была основана в 1989 г. В течение 17-летнего существования компания провела клинические испытания двенадцати препаратов, три из которых достигли последней фазы клинических испытаний. Icos также произвел антитела для других компаний, специализирующихся в области биотехнологии. Icos, прежде всегда, известна из-за тадалафила – препарата, предназначенного для лечения эректильной дисфункции, получившего впоследствии название "Сиалис" . Этот препарат был изначально разработан в компании GlaxoSmithKline, дальнейшие разработки проводила Icos, последующим производством занималась компания Eli Lilly and Company. Благодаря успешной рекламной кампании, проведенной Grey Worldwide Agency, продажи тадалафила позволили Icos завершить 2006 финансовый год с прибылью. Тадалафил стал единственным, впоследствии одобренным FDA, лекарством, разработанным компанией Icos. Другие препараты компании - LeukArrest – для лечения шока; – препарат, для лечения сепсиса были проверены в клинических испытаниях фазы III, но тестирование было прекращено после неперспективных результатов во время испытаний. Eli Lilly and Company приобрела Icos в январе 2007 г., большинство сотрудников корпорации Icos вскоре были уволены. (датская фирма, выполняющая субподрядные работы) купила остатки Icos, без последующих сокращений персонала.cos, без последующих сокращений персонала.
, Icos Corporation (Marca registrada ICOS), é uma companhia de biotecnologia norte-americana, que se dedica a descobrir e inovar o desenvolvimento de produtos proprietários com alto potencial comercial para o tratamento de doenças médicas sérias.
, Icos Corporation (trademark ICOS) was an A … Icos Corporation (trademark ICOS) was an American biotechnology company and the largest biotechnology company in the U.S. state of Washington, before it was sold to Eli Lilly and Company in 2007. It was founded in 1989 by David Blech, , , and George Rathmann, a pioneer in the industry and chief executive officer (CEO) and co-founder of Amgen, Icos focused on the development of drugs to treat inflammatory disorders. During its 17-year history, the company conducted clinical trials of twelve drugs, three of which reached the last phase of clinical trials. Icos also manufactured antibodies for other biotechnology companies. Icos is famous for tadalafil (Cialis), a drug used to treat erectile dysfunction. This drug was discovered by GlaxoSmithKline, developed by Icos, and manufactured and marketed in partnership with Eli Lilly. Boosted by a unique advertising campaign led by the Grey Worldwide Agency, sales from Cialis allowed Icos to become profitable in 2006. Cialis was the only drug developed by the company to be approved. LeukArrest, a drug to treat shock, and Pafase, developed for sepsis, were both tested in phase III clinical trials, but testing was discontinued after unpromising results during the trials. Eli Lilly acquired Icos in January 2007, and most of Icos's workers were laid off soon after. , a Danish contract manufacturer, bought the remnants of Icos and retained the remaining employees.Icos and retained the remaining employees.
|
| http://dbpedia.org/ontology/assets
|
2.41767E8
|
| http://dbpedia.org/ontology/dissolutionDate
|
"2007-01-29"^^xsd:date
|
| http://dbpedia.org/ontology/equity
|
-5.927E7
|
| http://dbpedia.org/ontology/fate
|
Acquired, Dissolved
|
| http://dbpedia.org/ontology/foundedBy
|
http://dbpedia.org/resource/George_Rathmann +
, http://dbpedia.org/resource/Christopher_Henney +
, http://dbpedia.org/resource/Robert_Nowinski +
|
| http://dbpedia.org/ontology/foundingYear
|
1989
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/George_Rathmann +
, http://dbpedia.org/resource/Chief_executive_officer +
|
| http://dbpedia.org/ontology/netIncome
|
-7.4842E7
|
| http://dbpedia.org/ontology/numberOfEmployees
|
700
|
| http://dbpedia.org/ontology/operatingIncome
|
-7.4242E7
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Tadalafil +
|
| http://dbpedia.org/ontology/revenue
|
7.141E7
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Icos_logo.png?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://web.archive.org/web/20080511210311/http:/www.cmcbio.com/ +
, http://www.cialis.com/ +
, http://www.lilly.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
882627
|
| http://dbpedia.org/ontology/wikiPageLength
|
41790
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1100076100
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Washington_%28state%29 +
, http://dbpedia.org/resource/PDL_BioPharma +
, http://dbpedia.org/resource/Icosahedron +
, http://dbpedia.org/resource/Multiple_organ_dysfunction_syndrome +
, http://dbpedia.org/resource/Eli_Lilly_and_Company +
, http://dbpedia.org/resource/Chronic_heart_failure +
, http://dbpedia.org/resource/Interstitial_cystitis +
, http://dbpedia.org/resource/Inflammation +
, http://dbpedia.org/resource/Indianapolis +
, http://dbpedia.org/resource/Sexual_dysfunction +
, http://dbpedia.org/resource/Atherosclerosis +
, http://dbpedia.org/resource/ICAM3 +
, http://dbpedia.org/resource/Grey_Global_Group +
, http://dbpedia.org/resource/Janet_Jackson +
, http://dbpedia.org/resource/Rheumatoid_arthritis +
, http://dbpedia.org/resource/Super_Bowl_XXXVIII +
, http://dbpedia.org/resource/Tadalafil +
, http://dbpedia.org/resource/Drug_development +
, http://dbpedia.org/resource/Copenhagen +
, http://dbpedia.org/resource/Virus +
, http://dbpedia.org/resource/Retrovirus +
, http://dbpedia.org/resource/Vardenafil +
, http://dbpedia.org/resource/File:Icos_Laboratories.JPG +
, http://dbpedia.org/resource/Protein_production +
, http://dbpedia.org/resource/Robert_Nowinski +
, http://dbpedia.org/resource/Aktieselskab +
, http://dbpedia.org/resource/File:Icos_logo.png +
, http://dbpedia.org/resource/Isaac_Blech +
, http://dbpedia.org/resource/Chemotherapy +
, http://dbpedia.org/resource/Biological_half-life +
, http://dbpedia.org/resource/Contract_manufacturer +
, http://dbpedia.org/resource/CMC_Biologics +
, http://dbpedia.org/resource/File:2006_0219FirstFUJIFOLDER0012.JPG +
, http://dbpedia.org/resource/Public_domain +
, http://dbpedia.org/resource/Bristol-Myers_Squibb +
, http://dbpedia.org/resource/Category:1989_establishments_in_Washington_%28state%29 +
, http://dbpedia.org/resource/Sildenafil +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/CD14 +
, http://dbpedia.org/resource/PDE5_inhibitor +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/United_States_Patent_and_Trademark_Office +
, http://dbpedia.org/resource/Abbott_Laboratories +
, http://dbpedia.org/resource/Food_and_Drug_Administration_%28United_States%29 +
, http://dbpedia.org/resource/Northwestern_University +
, http://dbpedia.org/resource/Category:2007_disestablishments_in_Washington_%28state%29 +
, http://dbpedia.org/resource/Myocardial_infarction +
, http://dbpedia.org/resource/Enzyme +
, http://dbpedia.org/resource/Erectile_dysfunction +
, http://dbpedia.org/resource/Seattle +
, http://dbpedia.org/resource/Pulmonary_arterial_hypertension +
, http://dbpedia.org/resource/Anterior_ischemic_optic_neuropathy +
, http://dbpedia.org/resource/Category:Defunct_companies_based_in_Bothell%2C_Washington +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Christopher_Henney +
, http://dbpedia.org/resource/Adverse_drug_reaction +
, http://dbpedia.org/resource/Multiple_sclerosis +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Shock_%28circulatory%29 +
, http://dbpedia.org/resource/Category:2007_mergers_and_acquisitions +
, http://dbpedia.org/resource/Golden_parachute +
, http://dbpedia.org/resource/CGMP_specific_phosphodiesterase_type_5 +
, http://dbpedia.org/resource/Amgen +
, http://dbpedia.org/resource/Bronchitis +
, http://dbpedia.org/resource/B-cell_lymphoma +
, http://dbpedia.org/resource/File:Tadalafil_20mg.jpg +
, http://dbpedia.org/resource/Initial_public_offering +
, http://dbpedia.org/resource/Emphysema +
, http://dbpedia.org/resource/Gene +
, http://dbpedia.org/resource/Informed_consent +
, http://dbpedia.org/resource/Platelet-activating_factor +
, http://dbpedia.org/resource/Chronic_obstructive_pulmonary_disease +
, http://dbpedia.org/resource/Resiniferatoxin +
, http://dbpedia.org/resource/Pfizer +
, http://dbpedia.org/resource/Tumor +
, http://dbpedia.org/resource/Benign_prostatic_hyperplasia +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_disestablished_in_2007 +
, http://dbpedia.org/resource/Antibody +
, http://dbpedia.org/resource/Biologic_medical_product +
, http://dbpedia.org/resource/Phospholipid +
, http://dbpedia.org/resource/Polyhedron +
, http://dbpedia.org/resource/Lipoprotein-associated_phospholipase_A2 +
, http://dbpedia.org/resource/Stock_option +
, http://dbpedia.org/resource/Endothelin_receptor_antagonist +
, http://dbpedia.org/resource/George_Rathmann +
, http://dbpedia.org/resource/White_blood_cell +
, http://dbpedia.org/resource/Female_sexual_dysfunction +
, http://dbpedia.org/resource/Priapism +
, http://dbpedia.org/resource/Stroke +
, http://dbpedia.org/resource/Severance_package +
, http://dbpedia.org/resource/Bothell%2C_Washington +
, http://dbpedia.org/resource/Cardiovascular_disease +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1989 +
, http://dbpedia.org/resource/Lymphocyte_function-associated_antigen_1 +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/GPC_Biotech +
, http://dbpedia.org/resource/Recombinant_DNA +
, http://dbpedia.org/resource/Immunex +
, http://dbpedia.org/resource/Layoff +
, http://dbpedia.org/resource/Capsaicin +
, http://dbpedia.org/resource/Sepsis +
, http://dbpedia.org/resource/University_of_Utah +
, http://dbpedia.org/resource/Blood_vessel +
, http://dbpedia.org/resource/Ischemic_stroke +
, http://dbpedia.org/resource/United_States_dollar +
, http://dbpedia.org/resource/PDE4_inhibitor +
, http://dbpedia.org/resource/Angiogenesis +
, http://dbpedia.org/resource/Heart_attack +
, http://dbpedia.org/resource/CHEK1 +
, http://dbpedia.org/resource/Super_Bowl_XXXVIII_halftime_show_controversy +
, http://dbpedia.org/resource/Macrophage +
, http://dbpedia.org/resource/Ownership_equity +
, http://dbpedia.org/resource/Bill_Gates +
, http://dbpedia.org/resource/Rovelizumab +
, http://dbpedia.org/resource/Pulmonary_hypertension +
, http://dbpedia.org/resource/Pancreatitis +
, http://dbpedia.org/resource/Pharmaceutical_industry +
, http://dbpedia.org/resource/Chuck_Grassley +
, http://dbpedia.org/resource/Sitaxentan +
, http://dbpedia.org/resource/Necrotizing_enterocolitis +
, http://dbpedia.org/resource/David_Blech +
, http://dbpedia.org/resource/Category:Eli_Lilly_and_Company +
, http://dbpedia.org/resource/Acute_respiratory_distress_syndrome +
, http://dbpedia.org/resource/Psoriasis +
, http://dbpedia.org/resource/Category:Biotechnology_companies_disestablished_in_2007 +
|
| http://dbpedia.org/property/assets
|
2.41767E8
|
| http://dbpedia.org/property/defunct
|
"2007-01-29"^^xsd:date
|
| http://dbpedia.org/property/equity
|
-5.927E7
|
| http://dbpedia.org/property/fate
|
Acquired, Dissolved
|
| http://dbpedia.org/property/foundation
|
Bothell, Washington, United States
|
| http://dbpedia.org/property/founder
|
Robert Nowinski
, Christopher Henney
, George Rathmann
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Paul Clark
, George Rathmann
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/Bothell%2C_Washington +
|
| http://dbpedia.org/property/locationCountry
|
United States
|
| http://dbpedia.org/property/logo
|
http://dbpedia.org/resource/File:Icos_logo.png +
|
| http://dbpedia.org/property/name
|
ICOS Corporation
|
| http://dbpedia.org/property/netIncome
|
-7.4842E7
|
| http://dbpedia.org/property/numEmployees
|
700
|
| http://dbpedia.org/property/operatingIncome
|
-7.4242E7
|
| http://dbpedia.org/property/products
|
http://dbpedia.org/resource/Tadalafil +
|
| http://dbpedia.org/property/revenue
|
7.141E7
|
| http://dbpedia.org/property/successor
|
CMC ICOS Biologics, Inc.
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Portal +
, http://dbpedia.org/resource/Template:Use_mdy_dates +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:End_date +
, http://dbpedia.org/resource/Template:See_also +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Spoken_Wikipedia +
, http://dbpedia.org/resource/Template:Main +
, http://dbpedia.org/resource/Template:Anchor +
, http://dbpedia.org/resource/Template:Start_date +
, http://dbpedia.org/resource/Template:About +
, http://dbpedia.org/resource/Template:Featured_article +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Eli_Lilly_and_Company +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_disestablished_in_2007 +
, http://dbpedia.org/resource/Category:1989_establishments_in_Washington_%28state%29 +
, http://dbpedia.org/resource/Category:Defunct_companies_based_in_Bothell%2C_Washington +
, http://dbpedia.org/resource/Category:2007_mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1989 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_disestablished_in_2007 +
, http://dbpedia.org/resource/Category:2007_disestablishments_in_Washington_%28state%29 +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Icos?oldid=1100076100&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Tadalafil_20mg.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/2006_0219FirstFUJIFOLDER0012.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Icos_logo.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/Icos_Laboratories.jpg +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://web.archive.org/web/20080511210311/http:/www.cmcbio.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Icos +
|
| http://xmlns.com/foaf/0.1/name
|
ICOS Corporation
|
| owl:sameAs |
https://global.dbpedia.org/id/3jrjB +
, http://ms.dbpedia.org/resource/Icos +
, http://www.wikidata.org/entity/Q4041254 +
, http://rdf.freebase.com/ns/m.03lhc0 +
, http://fa.dbpedia.org/resource/%D8%A7%DB%8C%DA%A9%D9%88%D8%B2 +
, http://id.dbpedia.org/resource/Icos +
, http://ru.dbpedia.org/resource/Icos +
, http://pt.dbpedia.org/resource/Icos_Corporation +
, http://dbpedia.org/resource/Icos +
, http://yago-knowledge.org/resource/Icos +
|
| rdf:type |
http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1990 +
, http://dbpedia.org/class/yago/WikicatCompaniesDisestablishedIn2007 +
, http://dbpedia.org/class/yago/WikicatDefunctCompaniesBasedInBothell%2CWashington +
, http://dbpedia.org/ontology/Company +
, http://schema.org/Organization +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
, http://umbel.org/umbel/rc/Business +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/Company108058098 +
|
| rdfs:comment |
Icos Corporation (Marca registrada ICOS), é uma companhia de biotecnologia norte-americana, que se dedica a descobrir e inovar o desenvolvimento de produtos proprietários com alto potencial comercial para o tratamento de doenças médicas sérias.
, Icos Corporation (trademark ICOS) was an A … Icos Corporation (trademark ICOS) was an American biotechnology company and the largest biotechnology company in the U.S. state of Washington, before it was sold to Eli Lilly and Company in 2007. It was founded in 1989 by David Blech, , , and George Rathmann, a pioneer in the industry and chief executive officer (CEO) and co-founder of Amgen, Icos focused on the development of drugs to treat inflammatory disorders. During its 17-year history, the company conducted clinical trials of twelve drugs, three of which reached the last phase of clinical trials. Icos also manufactured antibodies for other biotechnology companies.ibodies for other biotechnology companies.
, Icos (торговая марка ICOS) — корпорация, б … Icos (торговая марка ICOS) — корпорация, была крупнейшей на рынке биотехнологий в Вашингтоне (США) прежде, чем была продана компании Eli Lilly and Company в 2007 году . Компания Icos была основана в 1989 г. В течение 17-летнего существования компания провела клинические испытания двенадцати препаратов, три из которых достигли последней фазы клинических испытаний. Icos также произвел антитела для других компаний, специализирующихся в области биотехнологии.пециализирующихся в области биотехнологии.
, Icos Corporation (merek dagang ICOS) adala … Icos Corporation (merek dagang ICOS) adalah perusahaan bioteknologi Amerika dan perusahaan bioteknologi terbesar di negara bagian AS yaitu Washington, sebelum dijual kepada Eli Lilly And Company pada tahun 2007. Didirikan pada tahun 1989 oleh , , , dan , pelopor dalam industri dan Chief Executive Officer (CEO) dan co-founder dari Amgen, Icos difokuskan pada pengembangan obat-obatan untuk mengobati gangguan inflamasi. Selama sejarah 17 tahun, perusahaan melakukan dari dua belas narkoba, tiga di antaranya mencapai tahap terakhir dari uji klinis. Icos juga diproduksi antibodi untuk perusahaan bioteknologi lain.tibodi untuk perusahaan bioteknologi lain.
|
| rdfs:label |
Icos
, Icos Corporation
|
| rdfs:seeAlso |
http://dbpedia.org/resource/Lipoprotein-associated_phospholipase_A2 +
|
